
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15360809
[patent_doc_number] => 20200016169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => OPHTHALMIC SOLUTION OF BIMATOPROST
[patent_app_type] => utility
[patent_app_number] => 16/476138
[patent_app_country] => US
[patent_app_date] => 2018-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476138 | Ophthalmic solution of bimatoprost | Apr 6, 2018 | Issued |
Array
(
[id] => 14243763
[patent_doc_number] => 10272064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Pharmaceutical formulations for subcutaneous administration of furosemide
[patent_app_type] => utility
[patent_app_number] => 15/877865
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10820
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877865
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877865 | Pharmaceutical formulations for subcutaneous administration of furosemide | Jan 22, 2018 | Issued |
Array
(
[id] => 12675436
[patent_doc_number] => 20180116978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/849557
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/849557 | FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES | Dec 19, 2017 | Abandoned |
Array
(
[id] => 12621375
[patent_doc_number] => 20180098955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 15/839784
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/839784 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION | Dec 11, 2017 | Abandoned |
Array
(
[id] => 13574809
[patent_doc_number] => 20180338953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => Compositions and Methods for Non-Surgical Treatment of Ptosis
[patent_app_type] => utility
[patent_app_number] => 15/837325
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837325 | Compositions and Methods for Non-Surgical Treatment of Ptosis | Dec 10, 2017 | Abandoned |
Array
(
[id] => 16105537
[patent_doc_number] => 10695353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Methods of treating eye diseases associated with inflammation and vascular proliferation
[patent_app_type] => utility
[patent_app_number] => 15/807282
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16122
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807282
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807282 | Methods of treating eye diseases associated with inflammation and vascular proliferation | Nov 7, 2017 | Issued |
Array
(
[id] => 16335572
[patent_doc_number] => 10786510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Methods of treating eye diseases associated with inflammation and vascular proliferation
[patent_app_type] => utility
[patent_app_number] => 15/807166
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16141
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807166 | Methods of treating eye diseases associated with inflammation and vascular proliferation | Nov 7, 2017 | Issued |
Array
(
[id] => 12675652
[patent_doc_number] => 20180117050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION
[patent_app_type] => utility
[patent_app_number] => 15/807235
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807235
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/807235 | METHODS OF TREATING EYE DISEASES ASSOCIATED WITH INFLAMMATION AND VASCULAR PROLIFERATION | Nov 7, 2017 | Abandoned |
Array
(
[id] => 12880465
[patent_doc_number] => 20180185330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
[patent_app_type] => utility
[patent_app_number] => 15/801738
[patent_app_country] => US
[patent_app_date] => 2017-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15801738
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/801738 | NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) | Nov 1, 2017 | Abandoned |
Array
(
[id] => 12603159
[patent_doc_number] => 20180092883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => PHOSPHATASE INHIBITORS FOR TREATING OCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/796293
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796293 | PHOSPHATASE INHIBITORS FOR TREATING OCULAR DISEASES | Oct 26, 2017 | Abandoned |
Array
(
[id] => 16138927
[patent_doc_number] => 10702517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Bromodomain inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/788741
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 14741
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15788741
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/788741 | Bromodomain inhibitor | Oct 18, 2017 | Issued |
Array
(
[id] => 12603156
[patent_doc_number] => 20180092882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 15/782470
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782470
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782470 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION | Oct 11, 2017 | Abandoned |
Array
(
[id] => 15144835
[patent_doc_number] => 20190350895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => PHOTOCHROMATIC MODULATION WITH FLUORESCEIN FOR THE TREATMENT OF PHOTO-OCULODYNIA AND BLEPHAROSPASM
[patent_app_type] => utility
[patent_app_number] => 16/335343
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335343 | PHOTOCHROMATIC MODULATION WITH FLUORESCEIN FOR THE TREATMENT OF PHOTO-OCULODYNIA AND BLEPHAROSPASM | Sep 21, 2017 | Abandoned |
Array
(
[id] => 14578233
[patent_doc_number] => 20190216725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => DRUG DELIVERY SYSTEM FOR THE DELIVERY OF INTEGRASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/334393
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334393 | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF INTEGRASE INHIBITORS | Sep 14, 2017 | Abandoned |
Array
(
[id] => 12177375
[patent_doc_number] => 20180036311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'TREATMENT FOR HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES (HNPP)'
[patent_app_type] => utility
[patent_app_number] => 15/651931
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13918
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651931 | Treatment for hereditary neuropathy with liability to pressure palsies (HNPP) | Jul 16, 2017 | Issued |
Array
(
[id] => 14622015
[patent_doc_number] => 20190224375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/317101
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317101 | METHODS AND POLYMER COMPOSITIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS | Jul 12, 2017 | Abandoned |
Array
(
[id] => 14273295
[patent_doc_number] => 20190133932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Compositions, Methods and Kits for Treating a Contact Lens
[patent_app_type] => utility
[patent_app_number] => 16/096603
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096603 | Compositions, methods and kits for treating a contact lens | Apr 27, 2017 | Issued |
Array
(
[id] => 17539781
[patent_doc_number] => 11304884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Methods, compositions and uses relating thereto
[patent_app_type] => utility
[patent_app_number] => 16/095593
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8263
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095593 | Methods, compositions and uses relating thereto | Apr 20, 2017 | Issued |
Array
(
[id] => 11834561
[patent_doc_number] => 20170216281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'OPTICAL CORRECTION'
[patent_app_type] => utility
[patent_app_number] => 15/489950
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3060
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489950 | Optical correction | Apr 17, 2017 | Issued |
Array
(
[id] => 14182741
[patent_doc_number] => 20190111075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => STORAGE-STABLE OPHTHALMIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/089715
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089715 | Storage-stable ophthalmic composition | Apr 11, 2017 | Issued |